On Tuesday, November 26, 2024, HBHL hosted a Mentorship Lunch that brought together experienced industry professionals and over 40 McGill graduate students, postdocs and postgrads over coffee and...
We're happy to announce that the 2024 Amazing Brain Science Talks video recordings are officially live on our YouTube channel. Whether you're tuning in for the first time or revisiting your...
On Friday, November 8, 2024, NeuroSphere held its Demo Day at Maison Alcan in Montreal, with support from sponsors Gowling WLG and the Centre for Aging + Brain Health Innovation (CABHI). The event...
The Canadian Institutes of Health Research's Project Grant: Fall 2024 competition has approved 453 research grants for a total investment of approximately $411M, with 131 projects funded in Quebec....
Pain Medicine Fellow M. Ben Sasson presents:
"A Guideline That Could Redefine the Future Treatment of Chronic Spine Pain"
/paincentreCategory: Academic seminars and lectures
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
RSS